Cytomegalovirus infection leads to microvascular dysfunction and exacerbates hypercholesterolemia-induced responses.
Cytomegalovirus (CMV) persistently infects more than 60% of the worldwide population. In immunocompetent hosts, it has been implicated in several diseases, including cardiovascular disease, possibly through the induction of inflammatory pathways. Cardiovascular risk factors promote an inflammatory phenotype in the microvasculature long before clinical disease is evident. This study determined whether CMV also impairs microvascular homeostasis and synergizes with hypercholesterolemia to exaggerate these responses. Intravital microscopy was used to assess endothelium-dependent and -independent arteriolar vasodilation and venular leukocyte and platelet adhesion in mice after injection with either mock inoculum or murine CMV (mCMV). Mice were fed a normal (ND) or high-cholesterol (HC) diet beginning at 5 weeks postinfection (p.i.), or a HC diet for the final 4 weeks of infection. mCMV-ND mice exhibited impaired endothelium-dependent vasodilation versus mock-ND at 9 and 12 weeks and endothelium-independent arteriolar dysfunction by 24 weeks. Transient mild leukocyte adhesion occurred in mCMV-ND venules at 7 and 21 weeks p.i. HC alone caused temporary arteriolar dysfunction and venular leukocyte and platelet recruitment, which were exaggerated and prolonged by mCMV infection. The time of introduction of HC after mCMV infection determined whether mCMV+HC led to worse venular inflammation than either factor alone. These findings reveal a proinflammatory influence of persistent mCMV on the microvasculature, and suggest that mCMV infection enhances microvasculature susceptibility to both inflammatory and thrombogenic responses caused by hypercholesterolemia.
Khoretonenko
Mikhail V
MV
Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center, Shreveport, Louisiana 71130-3932, USA.
Leskov
Igor L
IL
Jennings
Stephen R
SR
Yurochko
Andrew D
AD
Stokes
Karen Y
KY
D000818:Animals; D001160:Arterioles / Q000276:immunology / Q000473:pathology*; D002448:Cell Adhesion; D002784:Cholesterol / Q000008:administration & dosage / Q000097:blood; D003587:Cytomegalovirus / Q000472:pathogenicity*; D003586:Cytomegalovirus Infections / Q000276:immunology* / Q000821:virology; D004279:DNA, Viral / Q000235:genetics; D004730:Endothelium, Vascular / Q000276:immunology / Q000473:pathology*; D006937:Hypercholesterolemia / Q000276:immunology* / Q000473:pathology / Q000821:virology; D007249:Inflammation / Q000209:etiology / Q000473:pathology; D051379:Mice; D008810:Mice, Inbred C57BL; D041681:NIH 3T3 Cells; D010973:Platelet Adhesiveness / Q000276:immunology; D016133:Polymerase Chain Reaction; D014664:Vasodilation; D014699:Venules / Q000276:immunology / Q000473:pathology*
D004279:DNA, Viral; D002784:Cholesterol
Am J Physiol Heart Circ Physiol. 2009 Apr;296(4):H937-45
19181963
Int J Microcirc Clin Exp. 1994 May-Jun;14(3):159-66
8082995
Cardiovasc Res. 2001 Feb 1;49(2):440-8
11164854
Circulation. 1997 Oct 7;96(7):2144-8
9337182
Transplantation. 2000 Feb 15;69(3):417-26
10706053
Transpl Int. 1993;6(6):341-7
8297464
Microcirculation. 2004 Dec;11(8):645-54
15726832
Curr Protoc Immunol. 2001 Aug;Chapter 19:Unit 19.7
18432758
In Vivo. 1993 Nov-Dec;7(6A):567-73
8193277
Kidney Int. 1996 Aug;50(2):526-37
8840282
Am J Cardiol. 1998 Apr 1;81(7):866-8
9555776
Atherosclerosis. 1992 Mar;93(1-2):41-52
1317707
Microcirculation. 1999 Sep;6(3):167-78
10501090
Am J Pathol. 1989 May;134(5):1151-7
2541613
Microbiol Immunol. 1997;41(2):121-9
9087954
Atherosclerosis. 2001 May;156(1):23-8
11368993
J Exp Med. 2000 Jan 3;191(1):189-94
10620617
Thromb Haemost. 2008 Mar;99(3):480-6
18327395
Microcirculation. 2006 Jul-Aug;13(5):377-88
16815823
Arterioscler Thromb Vasc Biol. 1997 Aug;17(8):1517-20
9301629
Am J Transplant. 2009 Nov;9(11):2453-8
19843027
J Virol Methods. 2003 Sep;112(1-2):107-13
12951218
Immunology. 1997 Sep;92(1):138-45
9370936
J Med Virol. 1994 Feb;42(2):170-4
8158112
Circ Res. 2004 Feb 6;94(2):239-44
14670846
J Infect Dis. 2001 Jan 15;183(2):226-231
11120928
J Clin Virol. 2008 Mar;41(3):218-23
18164235
Trends Cardiovasc Med. 2004 Jan;14(1):18-22
14720470
Microbes Infect. 2004 Oct;6(12):1056-62
15380774
Transplantation. 1999 Dec 15;68(11):1814-8
10609963
J Virol. 2005 Feb;79(4):2211-20
15681423
Am J Physiol. 1999 May;276(5):H1647-54
10330250
J Physiol. 2005 Feb 1;562(Pt 3):647-53
15611017
Circulation. 2004 Sep 14;110(11 Suppl 1):II207-12
15364864
J Clin Virol. 2002 Aug;25 Suppl 2:S159-71
12361766
J Am Coll Cardiol. 1999 Nov 15;34(6):1738-43
10577564
Stroke. 2002 Nov;33(11):2581-6
12411646
J Virol. 2004 May;78(9):4444-53
15078925
Immunology. 1991 Mar;72(3):355-60
1709139
Circulation. 2009 Aug 4;120(5):384-90
19620502
Arterioscler Thromb Vasc Biol. 2001 Oct;21(10):1662-7
11597942
Am J Physiol Gastrointest Liver Physiol. 2003 Jan;284(1):G123-9
12388188
Circulation. 2003 Aug 12;108(6):678-83
12900349
J Virol. 2007 Jul;81(14):7683-94
17507481
J Virol. 2006 Dec;80(23):11539-55
16987970
Transplantation. 1999 Jan 15;67(1):137-44
9921810
J Med Microbiol. 2004 Nov;53(Pt 11):1155-1160
15496396
Transplantation. 2000 Mar 27;69(6):1160-8
10762222
Atherosclerosis. 2002 Feb;160(2):305-10
11849652
Cell Mol Life Sci. 2010 Feb;67(4):499-511
20016997
J Virol. 2003 Apr;77(8):4588-96
12663765
Nature. 2002 Dec 19-26;420(6917):868-74
12490960
Am J Gastroenterol. 2001 Jul;96(7):2137-42
11467645
Virchows Arch B Cell Pathol Incl Mol Pathol. 1993;64(6):325-33
8148953
Am J Physiol Gastrointest Liver Physiol. 2003 Jun;284(6):G1027-33
12736150
Microbes Infect. 2004 Jan;6(1):17-24
14738889
Circulation. 1996 Jan 1;93(1):161-7
8616923
JAMA. 1989 Jun 23-30;261(24):3561-6
2542633
Microcirculation. 2009 Jan;16(1):84-96
19115139
Transplantation. 2003 Jun 15;75(11):1858-64
12811246
Arterioscler Thromb Vasc Biol. 1998 Oct;18(10):1583-8
9763530